Opens in a new tab
Skip to content
The image shows the "edx medical" logo. "edx" is written in lowercase white letters inside a blue hexagon, with the word "medical" in blue lowercase text to the right of the hexagon.

EDX Medical strengthens senior management team with two key appointments.

We are delighted to announce two new appointments to our senior management team.

Dr Keti Zeka will be joining as Head of R&D and Director of Laboratories and Dr Liam Dower as Head of Quality, Regulatory Affairs & Compliance. Both will be based at the company’s laboratory and head office in Cambridge, UK.                                                                                                            

Dr. Zeka is a highly experienced biochemist who holds a BSc and MSc in Medical Biotechnology (cum Laude) and a PhD in Chemical Engineering & Biotechnology Innovation from the University of L’Aquila, Italy. Since 2017, she has held multiple prestigious research fellowships at the University of Cambridge and University College London, in addition to her commercial experience as the PCR Team Lead at the National Covid-19 Testing Centre in Cambridge.

Dr Zeka commented : 

“I’m delighted to join EDX Medical as this role provides the opportunity for me to lead a team of exceptional scientists and technologists focused on pioneering the use of digital diagnostics for the benefit of patients”.

Dr Dower holds a first class B.Eng and PhD from the Department of Metallurgy & Engineering Materials, University of Strathclyde along with a postgraduate certificate in Intellectual Property management from Bournemouth University. He has previously held product development, quality and regulatory posts at Johnson & Johnson, Origin Sciences and Fluidic Analytics.

Dr Dower commented: 

“I’m delighted to be able to bring my wide experience of the regulated medical device sector to EDX Medical at this exciting time in the company’s growth”. 

Dr Mike Hudson, Chief Executive of EDX Medical Group plc, commented: 

“We are thrilled to  welcome Keti and Liam, where they will play pivotal roles developing and delivering ISO-15189 accredited laboratory services and ISO 13485 accredited point of care tests for our clients in the clinical sector”.

The image shows the "edx medical" logo. "edx" is written in lowercase white letters inside a blue hexagon, with the word "medical" in blue lowercase text to the right of the hexagon.

Recent articles

The Guardian logo in bold black text on a light background.
September 30, 2026

EDX Medical featured in The Guardian

A feature highlighting the growing importance of advanced health screening and early disease detection appeared…

Read more →
White bold text reading “Arnold Clark” on a dark grey background, representing the Arnold Clark Group’s commitment to employee health screening and wellbeing screening.
September 17, 2026

Major Employee Health and Wellbeing Screening Contract With Arnold Clark Group

EDX Medical is delighted is delighted to announce that it has entered into an initial…

Read more →
Four men stand indoors holding a sign that reads “Scottish Prostate Cancer Initiative. Early detection saves lives.” The men are smiling, and the background features dark wood panelling—a powerful reminder of the importance of Scottish Prostate Cancer testing events for early diagnosis and improved outcomes.
August 27, 2026

New testing events for Scottish Prostate Cancer Initiative

EDX Medical, as the lead delivery partner in the Scottish Prostate Cancer Initiative, has commenced…

Read more →
The image shows the "edx medical" logo. "edx" is written in lowercase white letters inside a blue hexagon, with the word "medical" in blue lowercase text to the right of the hexagon.

The Scottish Prostate Cancer Initiative

EDX Medical is launching a new employee health screening service offering a comprehensive range of tests.